Axim Biotechnologies, a pharmaceutical company targeting ocular diseases, signed an exclusive partnership agreement with Versea Ophthalmolics, a division of Versea Holdings, a healthcare company specializing in distributing ocular diagnostic and therapeutic products.
Axim Biotechnologies, Versea Holdings sign distribution agreement
